Size | Price | Stock | Qty |
---|---|---|---|
1mg |
|
||
Other Sizes |
|
ln Vitro |
ADP-sugar involved in microbial natural product biosynthesis, SepB, SepL, and SepC can convert sedoheptulose 7-phosphate to ADP-l-glycerol-β-d-mannoheptose [1]. SepL is involved in the biosynthesis of heptose in the core area of E, while SepB is an S-7-P isomerase. Coli LPS. The four-reaction relay d that transforms S-7-P into ADP-d-glycerol-β--mannoheptose is catalyzed by them[1]. Analogs of septacidin show promise as analgesics and anticancer drugs [1]. In fact, pig and poultry farming uses the anthelmintic Hygromycin B [1].
|
---|---|
References | |
Additional Infomation |
Sedoheptulose 7-phosphate is a ketoheptose phosphate consisting of sedoheptulose having a phosphate group at the 7-position. It is an intermediate metabolite in the pentose phosphate pathway. It has a role as a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a sedoheptulose derivative and a ketoheptose phosphate. It is functionally related to a sedoheptulose. It is a conjugate acid of a sedoheptulose 7-phosphate(2-).
D-Sedoheptulose 7-phosphate is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Sedoheptulose 7-phosphate has been reported in Drosophila melanogaster, Populus tremula, and other organisms with data available. Sedoheptulose 7-phosphate is a metabolite found in or produced by Saccharomyces cerevisiae. |
Molecular Formula |
C7H13O10P-2
|
---|---|
Molecular Weight |
288.14592
|
Exact Mass |
425.93
|
CAS # |
2646-35-7
|
PubChem CID |
165007
|
Appearance |
White to yellow solid powder
|
Density |
1.862g/cm3
|
Boiling Point |
751.4ºC at 760mmHg
|
Flash Point |
408.3ºC
|
Vapour Pressure |
4.61E-26mmHg at 25°C
|
Index of Refraction |
1.605
|
LogP |
-5
|
Hydrogen Bond Donor Count |
7
|
Hydrogen Bond Acceptor Count |
10
|
Rotatable Bond Count |
8
|
Heavy Atom Count |
18
|
Complexity |
313
|
Defined Atom Stereocenter Count |
4
|
SMILES |
C([C@H]([C@H]([C@H]([C@@H](C(=O)CO)O)O)O)O)OP(=O)(O)O
|
InChi Key |
JDTUMPKOJBQPKX-GBNDHIKLSA-N
|
InChi Code |
InChI=1S/C7H15O10P/c8-1-3(9)5(11)7(13)6(12)4(10)2-17-18(14,15)16/h4-8,10-13H,1-2H2,(H2,14,15,16)/t4-,5-,6-,7+/m1/s1
|
Chemical Name |
[(2R,3R,4R,5S)-2,3,4,5,7-pentahydroxy-6-oxoheptyl] dihydrogen phosphate
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
---|---|
Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.4704 mL | 17.3521 mL | 34.7041 mL | |
5 mM | 0.6941 mL | 3.4704 mL | 6.9408 mL | |
10 mM | 0.3470 mL | 1.7352 mL | 3.4704 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.